Decoy receptor proteins that trick viruses to bind to them should be resistant to viral escape
because viruses that require entry receptors cannot help but bind decoy receptors …

The COVID-19 pandemic is now approaching 2 years old, with more than 440 million people
infected and nearly six million dead worldwide, making it the most significant pandemic …

SARS-CoV-2 variants of interest and concern will continue to emerge for the duration of the
COVID-19 pandemic. To map mutations in the receptor-binding domain (RBD) of the spike …

New variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to
arise and prolong the coronavirus disease 2019 (COVID-19) pandemic. Here, we used a …

The SARS-CoV-2/COVID-19 pandemic continues to threaten global health and
socioeconomic stability. Experiments have revealed snapshots of many viral components …

SARS-CoV-2 has mutated during the global pandemic leading to viral adaptation to
medications and vaccinations. Here we describe an engineered human virus receptor …

Effective intervention strategies are urgently needed to control the COVID-19 pandemic.
Human angiotensin-converting enzyme 2 (ACE2) is a membrane-bound carboxypeptidase …

Abstract Angiotensin converting enzyme 2 (ACE2) is a key receptor present on cell surfaces
that directly interacts with the viral spike (S) protein of the severe acute respiratory syndrome …

Rationale About 50% of hospitalized coronavirus disease 2019 (COVID-19) patients with
diabetes mellitus (DM) developed myocardial damage. The mechanisms of direct SARS …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) enters the host cell by
binding to angiotensin‐converting enzyme 2 (ACE2) receptor. Other important proteins …